Knee Osteoarthritis: Clinical Updates and Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Orthopedics".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 548

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Regenerative Medicine for Locomotive Organ, Juntendo University School of Medicine, Tokyo 113-0033, Japan
Interests: knee osteoarthritis; prevention; pharmacological care; surgical intervention; physiotherapy; biotherapy; stem cell therapy
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo 113-0033, Japan
Interests: knee surgery; osteoarthritis; sports medicine; regenerative medicine

Special Issue Information

Dear Colleagues,

I'm excited to announce that I will be serving as the Guest Editor for the upcoming Special Issue titled "Knee Osteoarthritis: Clinical Updates and Perspectives". I believe that the ultimate goal in the treatment of knee osteoarthritis is to extend the "healthy lifespan." There are diverse approaches to achieve this goal.

From a preventive standpoint, lifestyle improvements such as diet and exercise are crucial. Approaching populations at a higher risk of developing knee osteoarthritis in the future, considering genetic and anatomical factors, represents a novel concept. Additionally, knee-preserving osteotomies aiming for "joint preservation" have seen significant progress in recent years.

In the field of biotherapy, cell therapies using autologous platelet-rich plasma and mesenchymal stem cells, as well as treatments utilizing liquid factors such as extracellular vesicles and exosomes, have undergone explosive development. However, when considering the goal of extending a healthy lifespan, it is essential not to persist in conservative treatments unnecessarily but to perform joint replacement surgery at the appropriate time.

In the complex realm of knee joint care, where the causes of pain are intricate, the most crucial premise is to thoroughly assess the patient's physical condition and, in conjunction with imaging diagnostics, appropriately evaluate the causes of pain for effective intervention.

For this Special Issue, I aim to gather insights from specialists at the forefront of these clinical updates and perspectives. Contributions are welcomed from clinical research, basic research with clinical relevance, animal experiments, literature reviews or any other relevant fields. I encourage submissions that share cutting-edge knowledge aimed at extending the healthy lifespan of patients.

Dr. Yoshitomo Saita
Dr. Shinnosuke Hada
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • knee osteoarthritis
  • diagnosis
  • cell therapy
  • platelet-rich plasma
  • exosome
  • knee osteotomy
  • arthroplasty
  • physiotherapy
  • conservative treatment
  • surgical treatment

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1276 KiB  
Article
Injection of Autologous Adipose Stromal Vascular Fraction in Combination with Autologous Conditioned Plasma for the Treatment of Advanced Knee Osteoarthritis Significantly Improves Clinical Symptoms
by Markus Klingenberg, Antoniya Dineva, Annika Hoyer, Barbara Kaltschmidt, Philipp Leimkühler, Thomas Vordemvenne, Andreas Elsner and Dirk Wähnert
J. Clin. Med. 2024, 13(11), 3031; https://doi.org/10.3390/jcm13113031 - 22 May 2024
Viewed by 147
Abstract
(1) Background: Osteoarthritis (OA) is the most common joint disease in the world. It is chronic, systemic, progressive and disabling. Orthobiologics have the potential to positively alter the course of this disease. Therefore, the aim of this study is to evaluate the efficacy [...] Read more.
(1) Background: Osteoarthritis (OA) is the most common joint disease in the world. It is chronic, systemic, progressive and disabling. Orthobiologics have the potential to positively alter the course of this disease. Therefore, the aim of this study is to evaluate the efficacy of SVF/ACP in the treatment of advanced osteoarthritis of the knee in an unfiltered patient population. We hypothesize that this therapy can improve the symptoms associated with osteoarthritis of the knee. We also hypothesize that there are patient-related factors that influence the efficacy of therapy. (2) Methods: Two hundred and thirteen patients with moderate to severe OA of the knee and SVF/ACP injection were recruited for this study. Patients were excluded if they did not provide informed consent or were not receiving SVF/ACP therapy. Pain, function, symptoms and quality of life were assessed using standardized scores (KOOS, WOMAC) before and after treatment. (3) Results: The VAS pain score was significantly reduced by at least 30% (p < 0.001). Knee function, as measured by the KOOS daily activity and sport scores, showed significant increases of 21% and 45%, respectively, at 6 months (p < 0.04). (4) Conclusions: Treatment of knee OA with SVF/ACP injection positively modifies the disease by significantly reducing pain and improving function. Full article
(This article belongs to the Special Issue Knee Osteoarthritis: Clinical Updates and Perspectives)
Show Figures

Figure 1

Back to TopTop